Global Optic Neuropathy Pipeline Review, H2 2019 – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Optic Neuropathy - Pipeline Review, H2 2019" drug pipelines has been added to ResearchAndMarkets.com's offering. This report provides an overview of the Optic Neuropathy (Ophthalmology) pipeline landscape. The review provides comprehensive information on the therapeutics under development for Optic Neuropathy (Ophthalmology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The